A Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate Real-World Safety, Tolerability, and Treatment Patterns of Pegcetacoplan (Syfovre) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

September 28, 2023

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2028

Conditions
Geographic Atrophy
Interventions
DRUG

Pegcetacoplan

Administered intravitreally (IVT) in eyes with geographic atrophy (GA)

Trial Locations (34)

11572

RECRUITING

OCLI Research Department (01-007), Oceanside

11590

RECRUITING

Long Island Vitreoretinal Consultants (01-013), Westbury

17402

RECRUITING

The Retina Care Center (01-034) - Satellite Site, York

18017

RECRUITING

Mid Atlantic Retina (01-001), Bethlehem

21209

RECRUITING

The Retina Care Center (01-023), Baltimore

21740

RECRUITING

Cumberland Valley Retina Consultants, P.C. (01-002), Hagerstown

RECRUITING

Mid Atlantic Retina Specialist (01-029), Hagerstown

22031

RECRUITING

The Retina Group of Washington (01-021), Fairfax

28803

RECRUITING

Western Carolina Retinal Associates, PA (01-009), Asheville

30060

RECRUITING

Georgia Retina (01-032), Marietta

30909

RECRUITING

South East Retina Center, PC (01-030), Augusta

32503

RECRUITING

Retina Specialty Institute (01-019), Pensacola

37203

RECRUITING

Tennessee Retina (01-033), Nashville

44122

RECRUITING

Retina Associates of Cleveland, Inc. (01-017), Cleveland

44130

RECRUITING

Retina Associates of Cleveland, Inc. (01-022), Cleveland

44505

RECRUITING

Retina Associates of Cleveland, Inc. (01-016), Youngstown

55435

RECRUITING

Retina Consultants of Minnesota, PLLC (01-025), Edina

57701

RECRUITING

Black Hills Regional Eye Institute (01-010), Rapid City

60304

RECRUITING

Illinois Retina Associates (01-037), Oak Park

75231

RECRUITING

Texas Retina Associates (01-028), Dallas

77384

RECRUITING

Retina Consultants of Texas (01-003), The Woodlands

77401

RECRUITING

Retina Consultants of Texas (01-004), Bellaire

79606

RECRUITING

Integrated Clinical Research (01-024), Abilene

80228

RECRUITING

Colorado Retina Associates, PLLC (01-011), Lakewood

90211

RECRUITING

Retina-Vitreous Associates Medical Group (01-020), Beverly Hills

92064

RECRUITING

Retina Consultants San Diego Inc. (01-018), Poway

92835

RECRUITING

Illinois Retina Associates (01-035), Fullerton

93103

RECRUITING

California Retina Consultants (01-027), Santa Barbara

93309

RECRUITING

California Retina Consultants (01-026), Bakersfield

94598

RECRUITING

Bay Area Retina Associates (01-005), Walnut Creek

95356

RECRUITING

Retinal Consultants Medical Group Inc (01-008), Modesto

98004

RECRUITING

Pacific Northwest Retina (01-036), Bellevue

08034

RECRUITING

Mid Atlantic Retina Research (01-014), Cherry Hill

08906

RECRUITING

Mid Atlantic Retina (01-031), Cherry Hill

Sponsors
All Listed Sponsors
lead

Apellis Pharmaceuticals, Inc.

INDUSTRY

NCT06161584 - A Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate Real-World Safety, Tolerability, and Treatment Patterns of Pegcetacoplan (Syfovre) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration | Biotech Hunter | Biotech Hunter